Related Articles
Stabilization of disease as an indicator of clinical benefit associated with chemotherapy in non-small cell lung cancer patients.
Similar survival benefits of a good response and stable disease to platinum-based chemotherapy in non-small cell lung cancer
The significance of multi‑line chemotherapy for advanced gastric cancer: A retrospective analysis
Erlotinib with pemetrexed/cisplatin for patients with EGFR wild-type lung adenocarcinoma with brain metastases
Phase II study on the combination of irinotecan plus cisplatin as a second‑line therapy in patients with advanced or recurrent gastric cancer